NCT01991509View on ClinicalTrials.gov

Safety and Bioavailability of IV and SC LBR-101

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Bioavailability and Pharmacokinetics
Interventions
BIOLOGICAL

LBR-101 IV

LBR-101 Administered Intravenously

BIOLOGICAL

LBR-101 SC

LBR-101 Administered Subcutaneously

Trial Locations (1)

78744

PPD Development, Austin

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT01991509 - Safety and Bioavailability of IV and SC LBR-101 | Biotech Hunter | Biotech Hunter